tiprankstipranks
Trending News
More News >
Merck & Company (MRK)
NYSE:MRK

Merck & Company (MRK) Stock Statistics & Valuation Metrics

Compare
13,265 Followers

Total Valuation

Merck & Company has a market cap or net worth of $196.28B. The enterprise value is $276.94B.
Market Cap$196.28B
Enterprise Value$276.94B

Share Statistics

Merck & Company has 2,516,394,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,516,394,000
Owned by Insiders0.05%
Owned by Institutions0.79%

Financial Efficiency

Merck & Company’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 37.86%.
Return on Equity (ROE)0.37
Return on Assets (ROA)0.22
Return on Invested Capital (ROIC)37.86%
Return on Capital Employed (ROCE)0.46
Revenue Per Employee879.01K
Profits Per Employee234.70K
Employee Count73,000
Asset Turnover0.83
Inventory Turnover2.01

Valuation Ratios

The current PE Ratio of Merck & Company is 14.77. Merck & Company’s PEG ratio is <0.01.
PE Ratio14.77
PS Ratio3.67
PB Ratio5.46
Price to Fair Value5.46
Price to FCF13.97
Price to Operating Cash Flow11.77
PEG Ratio<0.01

Income Statement

In the last 12 months, Merck & Company had revenue of 64.17B and earned 17.12B in profits. Earnings per share was 6.74.
Revenue64.17B
Gross Profit51.88B
Operating Income22.69B
Pretax Income19.94B
Net Income17.12B
EBITDA26.94B
Earnings Per Share (EPS)6.74

Cash Flow

In the last 12 months, operating cash flow was 21.47B and capital expenditures -3.37B, giving a free cash flow of 18.10B billion.
Operating Cash Flow21.47B
Free Cash Flow18.10B
Free Cash Flow per Share7.19

Dividends & Yields

Merck & Company pays an annual dividend of $0.81, resulting in a dividend yield of 4.05%
Dividend Per Share$0.81
Dividend Yield4.05%
Payout Ratio41.34%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.33
52-Week Price Change-36.83%
50-Day Moving Average87.43
200-Day Moving Average101.89
Relative Strength Index (RSI)33.61
Average Volume (3m)18.29M

Important Dates

Merck & Company upcoming earnings date is Apr 24, 2025, TBA Not Confirmed.
Last Earnings DateFeb 4, 2025
Next Earnings DateApr 24, 2025
Ex-Dividend DateMar 17, 2025

Financial Position

Merck & Company as a current ratio of 1.36, with Debt / Equity ratio of 80.13%
Current Ratio1.36
Quick Ratio1.15
Debt to Market Cap0.15
Net Debt to EBITDA0.89
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Merck & Company has paid 2.80B in taxes.
Income Tax2.80B
Effective Tax Rate0.14

Enterprise Valuation

Merck & Company EV to EBITDA ratio is 10.27, with an EV/FCF ratio of 15.29.
EV to Sales4.31
EV to EBITDA10.27
EV to Free Cash Flow15.29
EV to Operating Cash Flow12.89

Balance Sheet

Merck & Company has $13.69B in cash and marketable securities with $19.10B in debt, giving a net cash position of $23.42B billion.
Cash & Marketable Securities$13.69B
Total Debt$19.10B
Net Cash$23.42B
Net Cash Per Share$9.31
Tangible Book Value Per Share$3.26

Margins

Gross margin is 80.85%, with operating margin of 35.36%, and net profit margin of 26.68%.
Gross Margin80.85%
Operating Margin35.36%
Pretax Margin31.07%
Net Profit Margin26.68%
EBITDA Margin41.98%
EBIT Margin35.48%

Analyst Forecast

The average price target for Merck & Company is $108.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$108.00
Price Target Upside38.73% Upside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast6.85%
EPS Growth Forecast4577.79%

Scores

Smart Score9
AI Score74
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis